Autopsy report · NCT02541721

Effectiveness and Tolerability of LabiaStick#01 in Subjects With Symptomatic Non-hypertrophic Chronic Vulvar Dermatoses

“New study design will be made”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 4 months before it stopped.
• 3 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Health Products Research and Development Lda.

Sponsor type

University, hospital or other

Conditions

Chronic Disease of Skin

Interventions

LabiaStick#01

Participants

3

Sites

6

Countries

Portugal

Trials that died the same way

• Security and Efficacy of Dorilax® (Fixed Association of Paracetamol 350 mg, Carisoprodol 150 mg and Caffeine 50 mg) Plus Thermal Band Compared to Placebo Plus Thermal Band in the Treatment of Acute Low Back Pain.
  “Study design will be reformulated” (85% match in meaning)
• A Trial Measuring ART-123 Ability to Prevent Sensory Neuropathy in Unresectable mCRC Subjects w/Oxaliplatin-based Chemo
  “Study design was changed” (84% match in meaning)
• A Study in Patients With Advanced Parkinson's Disease to Assess the Relative Bioavailability of Levodopa Administered as ND0612 Subcutaneous Infusion Versus Levodopa Administered as Carbidopa-Levodopa Enteral Suspension
  “Decision to change the study design” (79% match in meaning)
• LEGION™ Revision Metal Hypersensitivity Study
  “Overhaul of Study Design” (78% match in meaning)
• RCT Comparing Standard Cannula Delivered FS, UGFS and ClariVein® in the Management of SVI
  “Study design has been substantially revised and a new registration will be made in the future.” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.